TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Medical Developments International Limited ( (AU:MVP) ) has provided an update.
Medical Developments International Ltd has announced that its Annual General Meeting will take place on October 10, 2025. A key agenda item will be the election of Directors, with nominations closing on August 27, 2025. This meeting is significant for stakeholders as it involves the election of leadership that will influence the company’s strategic direction and operations.
The most recent analyst rating on (AU:MVP) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Medical Developments International Limited stock, see the AU:MVP Stock Forecast page.
More about Medical Developments International Limited
Medical Developments International Ltd (MVP) is an Australian company specializing in emergency medical solutions aimed at enhancing patient outcomes. The company is a leader in the field of emergency pain relief and respiratory products, notably manufacturing Penthrox®, a fast-acting, non-opioid pain relief product used in various medical settings including hospitals, ambulance services, and the defense forces.
Average Trading Volume: 129,692
Technical Sentiment Signal: Buy
Current Market Cap: A$75.48M
Find detailed analytics on MVP stock on TipRanks’ Stock Analysis page.